Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Conditions

Hemangioma 3Vascular Malformations 1Hemangioma, Cavernous 1Hemangioma, Capillary 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Timolol 3Propranolol 3Solutions 2Prednisone 2Prednisolone 2Adrenal Cortex Hormones 2prednisolone phosphate 1Vincristine 1Saline Solution 1Ointments 1Mupirocin 1Methylprednisolone 1Imiquimod 1Gels 1Everolimus 1Adrenergic beta-Antagonists 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Hemangioma × Timolol × Clear all
NCT02731287 2018-11-14

Topical Timolol for Infantile Hemangioma in Early Proliferative Phase

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Phase 2 Completed
70 enrolled

Hemangioma

NCT02145884 2017-02-13

Topical Timolol Gel for the Treatment of Infantile Hemangiomas

Rady Children's Hospital, San Diego

Phase 2 Completed
26 enrolled

Hemangioma, Hemangioma, Cavernous

NCT01408056 2014-01-17

TOUCH

Children's Hospital of Philadelphia

Phase 2 Withdrawn

Hemangioma, Hemangioma, Capillary, Vascular Malformations

Data powered by HemOnc (CC BY 4.0) Colophon âš¡